Psykey, Inc.

Psykey, Inc.

CEOS
Psykey, Inc.US flagOther OTC
0.01
USD
+0.00
- -
94,746.00Market Cap
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
- -
- -
- -
- -
Basic EPS, GAAP
-0.47
-1.1
-0.83
-0.4
Free Cash Flow per Basic Share
- -
-0.86
-0.62
-0.19
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-0.01
-1.96
-2.67
-2.68
Tangible Book Value per Share
- -
0.59
0.08
-0.02
Basic Weighted Avg Shares
7
10
11
13
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
- -
1
1
- -
Net Income, GAAP
-3
-11
-9
-5
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Working Capital
- -
4
2
- -
LT Debt
- -
- -
1
- -
Total Equity
- -
6
1
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'08
Jun'08
Sep'08
ST Debt
- -
- -
- -
LT Borrowings
1
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
6
4
3

Working Capital

FRC

in mil. unless spec.
Mar'08
Jun'08
Sep'08
Total Current Assets
1
1
- -
Cash, Cash Equivalents & STI
1
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-85.77%
Free Cash Flow
- -
- -
-20.58%
Net Income, GAAP
- -
- -
-16.33%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.19
-0.38
-0.19
- -
-1.1
2007
-0.23
-0.24
-0.24
- -
-0.83
2008
-0.07
-0.04
-0.18
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Michael Maher
Full Time Employees
6
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
17 Belfield Road Toronto ON Canada M9W1E8
IPO Date
Feb 14, 2006
Business
Psykey, Inc. operates as an innovative wellness firm, concentrating on the discovery, advancement, and market introduction of mycology-derived entheogenic, adaptogenic, and nootropic compounds and blends. These formulations are integrated into its range of functional offerings, crafted to enhance well-being and daily performance. The company is additionally engaged in pioneering novel technologies designed for the precise formulation, improved absorption, and targeted delivery of entheogen-based treatments for the emerging psychedelic therapy sector. Its consumer-focused merchandise features functional mushroom-infused coffees and teas, dietary capsules, and convenient single-serving beverage powders. Formerly known as CeCors, Inc., the entity officially adopted the Psykey, Inc. designation in August 2021. Established in 2002, Psykey, Inc. maintains its principal operations in Toronto, Canada.

Company News

APIChat
  • Markets close lower, automakers, tariffs, and layoffs, Trump meets with CEOS, Tesla's future

  • CEOS Announces the Introduction of New VETCOMM App to Simplify Veteran Support and Increase Sales in Billion Dollar Veterans Benefits Market

  • CEOS Reports $1.03M in Q1 Sales; VETCOMM Drives Growth and Sets Stage for Strong Q2

  • Trump vows to target electric vehicles in meeting with oil CEOS -report

  • VETCOMM Set to Increase Sales Volume Through New Partnership with MVA - A National Call Center

  • VETCOMM Opens New Headquarters: Poised for Enhanced Operations and Team Collaboration

  • VETCOMM's Subscription Sales Surge Past $786,000 in 2023; CEOS Prepares for a Record First Quarter in 2024

  • Award-Winning Journalist Rafer Weigel Appointed Chief Content Officer at VETCOMM, Elevating CeCors' Strategic Content Vision

  • VETCOMM's New Conquer Brand No-Nicotine Pouches Seeks to Carve Out a Share of the Billion-Dollar Market

  • VETCOMM Appoints Expert Advisor to Propel Sales and Optimize Claims Processes

  • CeCors Reports Record Revenue Following VETCOMM Acquisition

  • VetComm Appoints Accomplished Operations Management Expert as COO to Drive Organizational Success as it Continues its Growth Plan

  • VetComm Announces Partnership with Veteran Forces to Offer Access to Benefits and Support for Nearly 2 Million Veterans

  • PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A.

  • PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A.

  • PsyKey Inc Announces Partnership with The Professional Gardener Co LTD to Develop and Distribute Innovative Products Designed for the Mushroom Production and Organic Farming Markets

  • PsyKey Inc Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development

  • PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development

  • PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board